Sickle cell disease trials in Greece

5 of 6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  Where

  Athens, Pátrai

  Age

  10 years to 65 years

  People

  192 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06975865
• Phase 2Taking people
  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  Where

  Athens

  Age

  12 years and over

  People

  70 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT06699849 · EU 2024-513440-29-00
• Phase 3Taking people
  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Where

  Athens, Larissa, Patras, Thessaloniki

  Age

  2 years and over

  People

  480 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06609226 · EU 2024-510805-27-00
• Phase 3Taking people
  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  Where

  Athens, Ioannina, Thessaloniki

  Age

  12 years and over

  People

  510 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06612268 · EU 2023-509175-16-00
• Phase 2/3Taking people
  A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  Where

  Athens

  Age

  12 years to 64 years

  People

  389 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05431088 · EU 2023-508766-14-00